Ad is loading...
JERTX vs MGLIX
JERTX vs MGLIX Comparison
Open Charts JERTX vs MGLIX
Janus Henderson Global Real Estate T
Price$11.70
Change-$0.10 (-0.85%)
VolumeN/A
Net Assets281.96M
MFS Global Real Estate I
Price$16.12
Change-$0.17 (-1.04%)
VolumeN/A
Net Assets2.27B
JERTX vs MGLIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
JERTX vs. MGLIX commentary
May 14, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JERTX is a Hold and MGLIX is a Buy.
FUNDAMENTALS
Fundamentals
MGLIX has more cash in the bank: 2.27B vs. JERTX (282M). MGLIX pays higher dividends than JERTX: MGLIX (2.60) vs JERTX (2.42). JERTX was incepted earlier than MGLIX: JERTX (16 years) vs MGLIX (16 years). MGLIX (0.95) is less costly to investors than JERTX (0.87). JERTX is a more actively managed with annual turnover of: 87.00 vs. MGLIX (48.00). MGLIX has a lower initial minimum investment than JERTX: MGLIX (0) vs JERTX (2500). JERTX annual gain was more profitable for investors over the last year : 7.06 vs. MGLIX (3.24). MGLIX return over 5 years is better than : 28.67 vs. JERTX (25.83).
| JERTX | MGLIX | JERTX / MGLIX | |
| Total Expense Ratio | 0.87 | 0.94 | 93% |
| Annual Report Gross Expense Ratio | 0.87 | 0.95 | 92% |
| Fund Existence | 16 years | 16 years | - |
| Gain YTD | 3.386 | 1.559 | 217% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 282M | 2.27B | 12% |
| Annual Yield % from dividends | 2.42 | 2.60 | 93% |
| Returns for 1 year | 7.06 | 3.24 | 218% |
| Returns for 3 years | -1.85 | -7.84 | 24% |
| Returns for 5 years | 25.83 | 28.67 | 90% |
| Returns for 10 years | 31.90 | 24.77 | 129% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VALIX | 13.18 | 0.21 | +1.62% |
| Value Line Capital Appreciation Investor | |||
| JAGLX | 64.76 | N/A | N/A |
| Janus Henderson Global Life Sciences T | |||
| RYSVX | 185.37 | N/A | N/A |
| Rydex S&P SmallCap 600 Pure Value A | |||
| FGEAX | 24.89 | N/A | N/A |
| Fidelity Advisor Glbl Capital Apprec A | |||
| JEMGX | 9.89 | N/A | N/A |
| JHancock Emerging Markets Equity R6 | |||